Xafinact 50mg Strip Of 10 Tablets

Specifications

Storage Tips

Store below 30°C

Dosage Type

Tablet

Salt composition

Safinamide (50 mg)

Packaging

Strip

Uses

Parkinson's disease

Safety Advice

Alcohol: Unsafe - Xafinact 50 Tablet May Cause Excessive Drowsiness With Alcohol. Pregnancy: Consult Your Doctor - Xafinact 50 Tablet May Be Unsafe To Use During Pregnancy. Although There Are Limited Studies In Humans, Animal Studies Have Shown Harmful Effects On The Developing Baby. Your Doctor Will Weigh The Benefits And Any Potential Risks Before Prescribing It To You. Please Consult Your Doctor. Breast Feeding: Consult Your Doctor - Xafinact 50 Tablet Is Probably Unsafe To Use During Breastfeeding. Limited Human Data Suggests That The Drug May Pass Into The Breastmilk And Harm The Baby. Driving: Unsafe - Xafinact 50 Tablet May Decrease Alertness, Affect Your Vision Or Make You Feel Sleepy And Dizzy. Do Not Drive If These Symptoms Occur. Kidney: Safe If Prescribed - Xafinact 50 Tablet Is Probably Safe To Use In Patients With Kidney Disease. Limited Data Available Suggests That Dose Adjustment Of Xafinact 50 Tablet May Not Be Needed In These Patients. Please Consult Your Doctor. Liver: Caution - Xafinact 50 Tablet Should Be Used With Caution In Patients With Liver Disease. Dose Adjustment Of Xafinact 50 Tablet May Be Needed. Please Consult Your Doctor.

Side Effects

Cough, Flu-Like Symptoms, Insomnia (Difficulty In Sleeping), Involuntary Muscle Movement, Fall, Nausea

Interaction with Drugs

Linezolid (Oral Route) Do not consume Safinamide with Linezolid. If Safinamide is essential, ensure a gap of At least 2 weeks between taking Safinamide and Linezolid. Please consult your doctor. Concurrent use may cause a fatal increase in blood pressure. Linezolid (Injection Route) Do not consume Safinamide with Linezolid. If Safinamide is essential, ensure a gap of At least 2 weeks between taking Safinamide and Linezolid. Please consult your doctor. Concurrent use may cause a fatal increase in blood pressure. Tetrabenazine (Oral Route) Do not consume Tetrabenazine with Safinamide. If Tetrabenazine is essential, ensure a gap of at least 2 weeks after discontinuing Safinamide. Please consult your doctor. Concomitant use may cause an increase in blood serotonin levels. Patients may experience agitation, increased body temperature, fast heartbeat, muscle rigidity, and loss of coordination. Bupropion (Oral Route) Do not consume Safinamide with Bupropion. If Safinamide is essential, ensure a gap of at least 24 hours after discontinuing Bupropion. Please consult your doctor. Concomitant use may cause high blood pressure and/or an increase in blood serotonin levels. Patients may experience agitation, increased body temperature, fast heartbeat, muscle rigidity, and loss of coordination. Linezolid (Oral Route) Do not consume Safinamide with Linezolid. If Safinamide is essential, ensure a gap of At least 2 weeks between taking Safinamide and Linezolid. Please consult your doctor. Concurrent use may cause a fatal increase in blood pressure.